09.08.14
Menlo Park, Calif.-based Ceterix Orthopaedics Inc., which makes minimally invasive surgical tools for orthopedic procedures, has received a U.S. patent for its Novostitch suture passer is used in the repair of meniscal tears and other soft-tissue joint injuries.
The new patent further protects the company’s products and methods that allow surgeons to arthroscopically pass suture through soft tissue in very tight joint compartments. The Novostitch suture passer allows the placement of a circumferential compression stitch in the knee meniscus, which is tightly surrounded by critical structures such as nerves, arteries and cartilage. This enables orthopedic surgeons to treat complex injuries that have not been amenable to repair in the past. The Novostitch technology can also be utilized in minimally invasive hip and shoulder procedures.
“This patent adds to our robust intellectual property portfolio with more than 160 issued claims now protecting our approach,” said John McCutcheon, president and CEO of Ceterix. “These patents are a testament to the innovative nature of our Novostitch technology now in use at more than 200 centers in the United States.
Arthroscopic surgery is a minimally invasive procedure in which an orthopedic surgeon treats the damaged joint through small incisions using specialized tools and guided by a tiny camera called an arthroscope. Meniscus surgery is the most common arthroscopic procedure in the United States, with roughly one million performed annually.
The new patent further protects the company’s products and methods that allow surgeons to arthroscopically pass suture through soft tissue in very tight joint compartments. The Novostitch suture passer allows the placement of a circumferential compression stitch in the knee meniscus, which is tightly surrounded by critical structures such as nerves, arteries and cartilage. This enables orthopedic surgeons to treat complex injuries that have not been amenable to repair in the past. The Novostitch technology can also be utilized in minimally invasive hip and shoulder procedures.
“This patent adds to our robust intellectual property portfolio with more than 160 issued claims now protecting our approach,” said John McCutcheon, president and CEO of Ceterix. “These patents are a testament to the innovative nature of our Novostitch technology now in use at more than 200 centers in the United States.
Arthroscopic surgery is a minimally invasive procedure in which an orthopedic surgeon treats the damaged joint through small incisions using specialized tools and guided by a tiny camera called an arthroscope. Meniscus surgery is the most common arthroscopic procedure in the United States, with roughly one million performed annually.